Peabody, J. W., DeMaria, L. M., Tamondong-Lachica, D., Florentino, J., Czarina Acelajado, M., Ouenes, O., . . . Burgon, T. (2017). Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: A randomized clinical utility trial. BMC Urol.

Peabody, John W., Lisa M. DeMaria, Diana Tamondong-Lachica, Jhiedon Florentino, M. Czarina Acelajado, Othman Ouenes, Jerome P. Richie, and Trever Burgon. "Impact of a Protein-based Assay That Predicts Prostate Cancer Aggressiveness On Urologists’ Recommendations for Active Treatment or Active Surveillance: A Randomized Clinical Utility Trial." BMC Urol 2017.

Peabody, John W., et al. "Impact of a Protein-based Assay That Predicts Prostate Cancer Aggressiveness On Urologists’ Recommendations for Active Treatment or Active Surveillance: A Randomized Clinical Utility Trial." BMC Urol 2017.